Invention Grant
US09309231B2 Bridged ring compounds as hepatitis C virus (HCV) inhibitors and pharmaceutical applications thereof 有权
桥连环化合物作为丙型肝炎病毒(HCV)抑制剂及其药物应用

Bridged ring compounds as hepatitis C virus (HCV) inhibitors and pharmaceutical applications thereof
Abstract:
Provided herein is a compound having Formula (I), or a stereoisomer, a geometric isomer, a tautomer, an N-oxide, a hydrate, a solvate, a metabolite, a pharmaceutically acceptable salt or a prodrug thereof, which can be used for treating HCV infection or a HCV disorder. Also provided herein are pharmaceutical compositions comprising the compounds disclosed herein, which can be used for treating HCV infection or a HCV disorder.
Information query
Patent Agency Ranking
0/0